Katie Falzone
Senior Vice President of Finance
Replay available
Invivyd, Inc. (NASDAQ: IVVD) Q4 2025 earnings conference call, held 2026-03-05. Replay captured from the company's public earnings webcast.

Senior Vice President of Finance
Chairman of InVivid's Board of Directors
Chief Commercial Officer
Chief Financial Officer
Chief Scientific Officer
Analyst, HC Wainwright
Analyst, BTIG
and thank you for standing by. Welcome to the Unvivid Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Katie Falzone, Senior Vice President of Finance. Please go ahead. Thank you, Operator. A short while ago, we issued a press release announcing our Q4 2025 financial results and recent business highlights. That press release and the slides that we are being used today on today's webcast can be found in the Investors section of the InVivid website under the Press Release and Events and Presentation sections respectively. Today's discussion will be led by Mark Aulia, Chairman of InVivid's Board of Directors. He is joined by Tim Lee, Chief Commercial Officer, Bill Duke, Chief Financial Officer, and Dr. Robbie Allen, Chief Scientific Officer. During today's discussion, we will be making forward-looking statements concerning, among other things, our corporate and commercial strategy, our research and development activities, our regulatory plans, certain financial expectations, our future prospects, and other statements that are not historical facts. These forward-looking statements are covered within the meaning of the Private Securities Litigation Reform Act and are subject to various risks assumptions, and uncertainties that may change over time and cause our actual results to differ materially from those...